Analysts See $-1.94 EPS for BeiGene, Ltd. (BGNE); Knowles (KN) Had 6 Analysts Last Week

April 16, 2018 - By Adrian Erickson

BeiGene, Ltd. (NASDAQ:BGNE) Logo

Among 13 analysts covering Knowles Corporation (NYSE:KN), 6 have Buy rating, 2 Sell and 5 Hold. Therefore 46% are positive. Knowles Corporation had 26 analyst reports since August 20, 2015 according to SRatingsIntel. The rating was downgraded by FBR Capital on Tuesday, October 27 to “Underperform”. The company was maintained on Friday, February 12 by FBR Capital. As per Monday, April 2, the company rating was maintained by Craig Hallum. The stock of Knowles Corporation (NYSE:KN) earned “Buy” rating by Roth Capital on Thursday, February 8. On Thursday, September 29 the stock rating was initiated by Roth Capital with “Buy”. The firm has “Buy” rating by Topeka Capital Markets given on Friday, February 12. The stock of Knowles Corporation (NYSE:KN) has “Hold” rating given on Wednesday, June 29 by Benchmark. The firm has “Hold” rating given on Thursday, September 3 by Zacks. As per Thursday, September 17, the company rating was downgraded by Zacks. Susquehanna maintained Knowles Corporation (NYSE:KN) on Thursday, April 5 with “Hold” rating. See Knowles Corporation (NYSE:KN) latest ratings:

05/04/2018 Broker: Susquehanna Rating: Hold New Target: $13.0000 Maintain
02/04/2018 Broker: Craig Hallum Rating: Buy New Target: $16.0000 Maintain
08/02/2018 Broker: Susquehanna Rating: Hold New Target: $15.0 Maintain
08/02/2018 Broker: Roth Capital Rating: Buy New Target: $18.0 Maintain
08/02/2018 Broker: Craig Hallum Rating: Buy New Target: $17.0 Maintain
21/12/2017 Broker: PiperJaffray Rating: Neutral New Target: $15.5 Initiates Coverage On
20/12/2017 Broker: Piper Jaffray Rating: Hold New Target: $15.5 Initiate
05/12/2017 Broker: Robert W. Baird Rating: Buy New Target: $18.0 Maintain
25/10/2017 Broker: Susquehanna Rating: Hold New Target: $16.0

Analysts expect BeiGene, Ltd. (NASDAQ:BGNE) to report $-1.94 EPS on May, 9.They anticipate $0.67 EPS change or 52.76% from last quarter’s $-1.27 EPS. After having $-2.19 EPS previously, BeiGene, Ltd.’s analysts see -11.42% EPS growth. The stock decreased 0.11% or $0.19 during the last trading session, reaching $168.03. About 132,947 shares traded. BeiGene, Ltd. (NASDAQ:BGNE) has risen 354.57% since April 16, 2017 and is uptrending. It has outperformed by 343.02% the S&P500.

BeiGene, Ltd., a clinical-stage biopharmaceutical company, discovers and develops molecularly-targeted and immuno-oncology drugs for the treatment of cancer. The company has market cap of $8.94 billion. The company's clinical stage drug candidates include BGB-3111, a small molecule BTK inhibitor for the treatment of various lymphomas; BGB-A317, a humanized monoclonal antibody for solid-organ and blood-borne cancers; BGB-290, an inhibitor of PARP1 and PARP2 for the treatment of homologous recombination deficient cancers; and BGB-283, a small molecule RAF dimer inhibitor to treat cancers with aberrations in the mitogen-activated protein kinase pathway, including BRAF mutations and KRAS/NRAS gene mutations. It currently has negative earnings. The Company’s preclinical programs comprise a PD-L1 monoclonal antibody, an additional RAF dimer inhibitor, a TIM-3 cell surface protein monoclonal antibody, and a BTK inhibitor for non-oncology indications.

The stock decreased 2.52% or $0.32 during the last trading session, reaching $12.36. About 812,993 shares traded. Knowles Corporation (NYSE:KN) has declined 33.21% since April 16, 2017 and is downtrending. It has underperformed by 44.76% the S&P500.

Knowles Corporation designs, manufactures, and sells micro-acoustic, audio processing, and specialty component solutions to the mobile consumer electronics, communications, medical, military, aerospace, and industrial markets worldwide. The company has market cap of $1.11 billion. The firm operates in two divisions, Mobile Consumer Electronics and Specialty Components. It has a 16.41 P/E ratio. The Mobile Consumer Electronics segment creates and makes acoustic products, including microphones and audio processing technologies for use in mobile handsets, wearables, and other consumer electronic devices.

BeiGene, Ltd. (NASDAQ:BGNE) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>